search
Back to results

Diet Intervention and GEnetic STudy (DIGEST-Pilot) (DIGEST)

Primary Purpose

Cardiovascular Diseases, Inflammation, Dyslipidemias

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Prudent Diet
Typical Western Diet
Sponsored by
McMaster University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cardiovascular Diseases focused on measuring diet, dietary pattern, gene, gene expression, epigenomics, diet-gene interaction, inflammation, 9p21, fruits, vegetables

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 18-80 years old
  • non-smokers
  • Body-Mass-Index <=30 kg/m^2
  • willing and able to cook, prepare, and eat provided study foods

Exclusion Criteria:

  • Aged below 18 years or above 80 years
  • current tobacco smoking
  • Body mass index above 30 kg/m2
  • Unwillingness or inability to cook, prepare and eat provided study foods (e.g. for medical, philosophical, or religious reasons)
  • Excessive use of alcohol (>14 drinks/week in men; >7 drinks/week in women)
  • Significant morbidity that would interfere with participation or assessment, including :
  • Cancer
  • HIV
  • chronic renal disease
  • renal failure
  • Hepatitis/Jaundice
  • Liver Disease
  • Chronic Obstructive Pulmonary Disease
  • Inflammatory bowel disease (Crohn's / Colitis)
  • High blood or urine sugar/diabetes
  • High blood cholesterol or triglycerides
  • Angina/Heart attack/Coronary artery disease
  • Heart failure
  • Other heart disease
  • Angioplasty (balloon opening of an artery) or coronary bypass surgery
  • Medications or nutritional supplements (including multivitamins) that could affect outcome measurements. Excluded medications would include:
  • Lipid/cholesterol lowering pills
  • Insulin/oral hypoglycemic agents
  • Medication for stroke
  • Antibiotics
  • oral contraceptives
  • hormone replacement therapy
  • non-steroidal anti-inflammatory drugs
  • corticosteroids
  • unwillingness to stop nutritional supplements 1 week prior to and for duration of intervention
  • anticipated difficulties maintaining body weight (e.g. athletic training)

Sites / Locations

  • McMaster University

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Typical Western Diet

Prudent Diet

Arm Description

The comparator dietary pattern ("Typical Western Diet") approximates the inflammatory dietary pattern typically consumed by North Americans. It contains refined grains, processed foods, dairy fat, meats, sugar and high glycemic index foods, and few fruits, nuts, legumes, and vegetables. The fruits and vegetables are highly processed (e.g. juices) and lower in micronutrients than those in the intervention diet. The saturated fat content of this diet does not meet national guidelines for health. The polyunsaturated fat:saturated fat ratio is ~0.5 (low).

The experimental dietary pattern ("Prudent Diet") is based on intakes of foods hypothesized to have beneficial effects on inflammation and long-term health. This dietary pattern includes micronutrient and macronutrient levels consistent with healthy eating in epidemiological studies and randomized controlled trials. The diet is constructed with low-fat dairy products, fish, chicken, and lean meats to minimize saturated fat and increase protein and calcium. The diet is rich in fruits, vegetables, whole grains, nuts, legumes, and seeds that are good sources of potassium, magnesium, and dietary fiber. This diet provides a 'favorable' macronutrient profile that is low in saturated fat, has a polyunsaturated/saturated fat ratio of ~1.0 (high), and low in high glycemic index carbohydrates.

Outcomes

Primary Outcome Measures

gene expression measuring ANRIL production
epigenetic marks

Secondary Outcome Measures

high-sensitivity C-reactive protein
Biomarker of inflammation
interferon-alpha-21
Biomarker of inflammation
interferon-gamma
Biomarker of inflammation
interleukin-1-alpha
Biomarker of inflammation
total cholesterol
lipid risk factor for cardiovascular disease
low-density lipoprotein-cholesterol
lipid risk factor for cardiovascular disease
high-density lipoprotein-cholesterol
lipid risk factor for cardiovascular disease
apolipoprotein-B
lipid risk factor for cardiovascular disease
fasting glucose
indicator of insulin resistance
systolic blood pressure
mmHg
diastolic blood pressure
mmHg
interleukin-6
Biomarker of inflammation

Full Information

First Posted
July 28, 2012
Last Updated
June 5, 2016
Sponsor
McMaster University
search

1. Study Identification

Unique Protocol Identification Number
NCT01658137
Brief Title
Diet Intervention and GEnetic STudy (DIGEST-Pilot)
Acronym
DIGEST
Official Title
Dietary Intervention Trial to Understand the Mechanism Underlying the 9p21 Variant Interaction With High Fruits and Vegetable Consumption
Study Type
Interventional

2. Study Status

Record Verification Date
June 2016
Overall Recruitment Status
Unknown status
Study Start Date
July 2012 (undefined)
Primary Completion Date
December 2016 (Anticipated)
Study Completion Date
December 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
McMaster University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Genetic factors contribute to risk factors for cardiovascular disease, such as blood lipids, blood pressure, obesity, diabetes, and may also influence dietary choices, physical activity, and responses to stress. The most robust genetic variant associated with myocardial infarction (MI) is the 9p21 variant, which may raise the risk of MI by up to 40% in those who carry 2 copies of the gene. The investigators recently found that among those who carry the 9p21 variant, the risk of MI may be "turned off" if individuals eat a diet high in fruits and vegetables. The investigators seek to determine how a "prudent" or "anti-inflammatory" diet interacts with the 9p21 risk allele to alter the risk of MI.
Detailed Description
Cardiovascular disease (CVD) is the leading cause of death globally. The majority of CVD is explained by conventional risk factors including cigarette smoking, abnormal lipids, high blood pressure, obesity, diabetes, and health behaviours including dietary intake, physical activity, and psychosocial stressors. Genetic factors contribute to the development of these risk factors, and directly to CVD through other novel pathways. Since the advent of high throughput chip-based genotyping, more than 30 genetic variants have been found to be associated with myocardial infarction. The most robust genetic variant which has been consistently associated with myocardial infarction and other forms of arterial disease is the 9p21 variant. This genetic variant located on Chromosome 9 is common in the population, with 50% of people carrying one copy of the risk allele, and an additional 25% of the population carrying two copies of the risk allele. Compared with those with no copies of the risk allele, the risk of myocardial infarction with one copy of the risk allele is 15-20% higher, and the increased risk among carriers of 2 risk alleles is 20-40%. To date the exact mechanism by which the 9p21 variant increases the risk of myocardial infarction is unknown, although some data suggests that other genes and pathways associated with cell proliferation and inflammation are involved. Recently we made the observation that among carriers of the 9p21 variant, the risk of MI may be "turned off" if individuals consumed a diet high in fruits and vegetables. However the "mechanism" underlying this interaction is unknown. We seek to discover how a "Prudent" (i.e. anti-inflammatory) diet interacts with the 9p21 risk allele(s) to alter the risk of myocardial infarction. We postulate that a "Prudent" diet (i.e. a diet high in fruits, vegetables, whole grains, non-processed foods) in comparison to a "Western" or "inflammatory diet" (eg, a typical North American diet high in saturated fats and processed foods) will differentially alter the gene expression (measured by RNA) of the 9p21 locus, change the epigenetic marks in this region, and alter several inflammatory markers suspected to mediate the effect of 9p21 on CVD risk (eg, hs-CRP, IF-alpha21, IFN-γ , interleukin 1-alpha, interleukin 1-beta, and interleukin 6) among people with one or two copies of the risk allele compared to people without the risk allele. The proposed study offers an unique approach to studying dietary relationships with endpoints believed to be influenced by 9p21 gene variants. Rather than testing nutritional supplements, our results will be generalizable to the setting of most dietary counseling practices, which aim to alter dietary patterns, not specific nutrients. This trial will help us to unravel the basis for gene-diet interactions and gain a greater understanding of how inflammation is linked to the development of atherosclerosis, CVD, and possibly some cancers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Diseases, Inflammation, Dyslipidemias, Blood Pressure, Hyperglycemia
Keywords
diet, dietary pattern, gene, gene expression, epigenomics, diet-gene interaction, inflammation, 9p21, fruits, vegetables

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
84 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Typical Western Diet
Arm Type
Active Comparator
Arm Description
The comparator dietary pattern ("Typical Western Diet") approximates the inflammatory dietary pattern typically consumed by North Americans. It contains refined grains, processed foods, dairy fat, meats, sugar and high glycemic index foods, and few fruits, nuts, legumes, and vegetables. The fruits and vegetables are highly processed (e.g. juices) and lower in micronutrients than those in the intervention diet. The saturated fat content of this diet does not meet national guidelines for health. The polyunsaturated fat:saturated fat ratio is ~0.5 (low).
Arm Title
Prudent Diet
Arm Type
Experimental
Arm Description
The experimental dietary pattern ("Prudent Diet") is based on intakes of foods hypothesized to have beneficial effects on inflammation and long-term health. This dietary pattern includes micronutrient and macronutrient levels consistent with healthy eating in epidemiological studies and randomized controlled trials. The diet is constructed with low-fat dairy products, fish, chicken, and lean meats to minimize saturated fat and increase protein and calcium. The diet is rich in fruits, vegetables, whole grains, nuts, legumes, and seeds that are good sources of potassium, magnesium, and dietary fiber. This diet provides a 'favorable' macronutrient profile that is low in saturated fat, has a polyunsaturated/saturated fat ratio of ~1.0 (high), and low in high glycemic index carbohydrates.
Intervention Type
Other
Intervention Name(s)
Prudent Diet
Intervention Description
This intervention lasts 2 weeks (14 days).
Intervention Type
Other
Intervention Name(s)
Typical Western Diet
Intervention Description
This intervention lasts 2 weeks (14 days).
Primary Outcome Measure Information:
Title
gene expression measuring ANRIL production
Time Frame
baseline and 2 weeks
Title
epigenetic marks
Time Frame
baseline and 2 weeks
Secondary Outcome Measure Information:
Title
high-sensitivity C-reactive protein
Description
Biomarker of inflammation
Time Frame
baseline and 2 weeks
Title
interferon-alpha-21
Description
Biomarker of inflammation
Time Frame
baseline and 2 weeks
Title
interferon-gamma
Description
Biomarker of inflammation
Time Frame
baseline and 2 weeks
Title
interleukin-1-alpha
Description
Biomarker of inflammation
Time Frame
baseline and 2 weeks
Title
total cholesterol
Description
lipid risk factor for cardiovascular disease
Time Frame
baseline and 2 weeks
Title
low-density lipoprotein-cholesterol
Description
lipid risk factor for cardiovascular disease
Time Frame
baseline and 2 weeks
Title
high-density lipoprotein-cholesterol
Description
lipid risk factor for cardiovascular disease
Time Frame
baseline and 2 weeks
Title
apolipoprotein-B
Description
lipid risk factor for cardiovascular disease
Time Frame
baseline and 2 weeks
Title
fasting glucose
Description
indicator of insulin resistance
Time Frame
baseline and 2 weeks
Title
systolic blood pressure
Description
mmHg
Time Frame
baseline and 2 weeks
Title
diastolic blood pressure
Description
mmHg
Time Frame
baseline and 2 weeks
Title
interleukin-6
Description
Biomarker of inflammation
Time Frame
baseline and 2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18-80 years old non-smokers Body-Mass-Index <=30 kg/m^2 willing and able to cook, prepare, and eat provided study foods Exclusion Criteria: Aged below 18 years or above 80 years current tobacco smoking Body mass index above 30 kg/m2 Unwillingness or inability to cook, prepare and eat provided study foods (e.g. for medical, philosophical, or religious reasons) Excessive use of alcohol (>14 drinks/week in men; >7 drinks/week in women) Significant morbidity that would interfere with participation or assessment, including : Cancer HIV chronic renal disease renal failure Hepatitis/Jaundice Liver Disease Chronic Obstructive Pulmonary Disease Inflammatory bowel disease (Crohn's / Colitis) High blood or urine sugar/diabetes High blood cholesterol or triglycerides Angina/Heart attack/Coronary artery disease Heart failure Other heart disease Angioplasty (balloon opening of an artery) or coronary bypass surgery Medications or nutritional supplements (including multivitamins) that could affect outcome measurements. Excluded medications would include: Lipid/cholesterol lowering pills Insulin/oral hypoglycemic agents Medication for stroke Antibiotics oral contraceptives hormone replacement therapy non-steroidal anti-inflammatory drugs corticosteroids unwillingness to stop nutritional supplements 1 week prior to and for duration of intervention anticipated difficulties maintaining body weight (e.g. athletic training)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sonia S Anand, MD, PhD
Organizational Affiliation
McMaster University; Hamilton Health Sciences Center; Population Health Research Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
McMaster University
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8S 4K1
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Because sensitive genetic material was collected as part of this pilot study, data from this study will not be shared.
Citations:
PubMed Identifier
21295845
Citation
Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet. 2011 Feb 12;377(9765):529-32. doi: 10.1016/S0140-6736(10)62346-X. Epub 2011 Feb 4. No abstract available.
Results Reference
background
PubMed Identifier
22129254
Citation
O'Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N Engl J Med. 2011 Dec 1;365(22):2098-109. doi: 10.1056/NEJMra1105239. No abstract available.
Results Reference
background
PubMed Identifier
17478681
Citation
McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, Boerwinkle E, Hobbs HH, Cohen JC. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007 Jun 8;316(5830):1488-91. doi: 10.1126/science.1142447. Epub 2007 May 3.
Results Reference
background
PubMed Identifier
22022235
Citation
Do R, Xie C, Zhang X, Mannisto S, Harald K, Islam S, Bailey SD, Rangarajan S, McQueen MJ, Diaz R, Lisheng L, Wang X, Silander K, Peltonen L, Yusuf S, Salomaa V, Engert JC, Anand SS; INTERHEART investigators. The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study. PLoS Med. 2011 Oct;8(10):e1001106. doi: 10.1371/journal.pmed.1001106. Epub 2011 Oct 11.
Results Reference
background
PubMed Identifier
19364995
Citation
Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009 Apr 13;169(7):659-69. doi: 10.1001/archinternmed.2009.38.
Results Reference
background
PubMed Identifier
11010931
Citation
Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000 Oct;72(4):912-21. doi: 10.1093/ajcn/72.4.912.
Results Reference
background

Learn more about this trial

Diet Intervention and GEnetic STudy (DIGEST-Pilot)

We'll reach out to this number within 24 hrs